Market Cap

EUR 28.1B

Volume

3.2M

Cash and Equivalents

EUR 4.7B

EBITDA

EUR 11.5B

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

EUR 27.5B

Profit Margin

58.57%

52 Week High

EUR 53.80

52 Week Low

EUR 24.96

Dividend

0.38%

Price / Book Value

0.79

Price / Earnings

-9.02

Price / Tangible Book Value

-1.37

Enterprise Value

EUR 69.8B

Enterprise Value / EBITDA

5.96

Operating Income

EUR 7.9B

Return on Equity

-8.13%

Return on Assets

4.04

Cash and Short Term Investments

EUR 4.7B

Debt

EUR 46.3B

Equity

EUR 35.8B

Revenue

EUR 47.0B

Unlevered FCF

EUR 198.8M

Sector

Pharmaceuticals

Category

N/A